In development: Guidance, quality standards and advice
Showing 11 to 11 of 11
| Title | Type | Expected publication date |
|---|---|---|
| Teclistamab with daratumumab for treating relapsed or refractory multiple myeloma after 1 or more therapies [ID6201] | Technology appraisal guidance |